RESHAPE LIFESCIENCES INC. Debt Conversion, Converted Instrument, Amount
RESHAPE LIFESCIENCES INC. reported Debt Conversion, Converted Instrument, Amount of $20.30 million for the 12-month period ending 2016-12-31, per its 10-K filed 2017-03-08.
Discontinued › Cash Flow › Financing Activities
us-gaap:DebtConversionConvertedInstrumentAmount1 · last filed 2017-03-08
- RESHAPE LIFESCIENCES INC. debt conversion, converted instrument, amount for the quarter ending 2016-12-31 was $17.10M.
- RESHAPE LIFESCIENCES INC. debt conversion, converted instrument, amount for the quarter ending 2016-09-30 was $0.00.
- RESHAPE LIFESCIENCES INC. debt conversion, converted instrument, amount for the quarter ending 2016-06-30 was $1.69M.
- RESHAPE LIFESCIENCES INC. debt conversion, converted instrument, amount for the quarter ending 2016-03-31 was $1.51M.
- RESHAPE LIFESCIENCES INC. debt conversion, converted instrument, amount for fiscal 2016 was $20.30M, a 20200.00% increase from fiscal 2015.
- RESHAPE LIFESCIENCES INC. debt conversion, converted instrument, amount for fiscal 2015 was $100.00K.
| Period end | Debt Conversion, Converted Instrument, Amount 3 month | Debt Conversion, Converted Instrument, Amount 6 month | Debt Conversion, Converted Instrument, Amount 9 month | Debt Conversion, Converted Instrument, Amount 12 month | Debt Conversion, Converted Instrument, Amount 12 month as first filed |
|---|---|---|---|---|---|
| 2016-12-31 | $17.10M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-08 | $17.10M derived: sum of 2 quarters · filed 2017-03-08 | $18.79M derived: sum of 3 quarters · filed 2017-03-08 | $20.30M 10-K · filed 2017-03-08 | |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | $1.69M derived: sum of 2 quarters · filed 2016-11-14 | $3.20M 10-Q · filed 2016-11-14 | ||
| 2016-06-30 | $1.69M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-12 | $3.20M 10-Q · filed 2016-08-12 | |||
| 2016-03-31 | $1.51M 10-Q · filed 2016-05-10 | ||||
| 2015-12-31 | $100.00K 10-K · filed 2017-03-08 | $109.50K 10-K · filed 2016-03-28 |